Driving a New Era of Patient Centricity - Interview with Ian Marks

Who Would Have Thought - Digital Health Innovation - A podcast by Sacha Francois Heppell

Categorie:

In this episode, we welcome Ian Marks, Senior R&D Innovation Leader and Global Vice President of Life Sciences at Salesforce, a leading software company committed to transforming healthcare. Ian is leading the push to reimagine healthcare and build strategic capabilities that improve patients' lives. Tune in to discover the innovation initiatives that are currently fueling the digital transformation of healthcare. We dive into the future of personalized, patient-centered healthcare and the impacts Salesforce is having on the advancement of life sciences. Ian speaks on how the healthcare system is moving from reactive to proactive and predictive, the main issues his team will be focusing on in 2021, and how Salesforce is working to improve pharmaceutical distribution models and increase compliance for better outcomes, especially with the covid-19 vaccine. He also gives insight into how healthcare and pharmaceutical companies can increase patient-centric solutions, emphasizing awareness, education, supporting diagnosis and treatment through healthcare providers, and ongoing engagement to ensure patient compliance. Curious to know Ian’s candid thoughts on the future of life sciences and innovation? Tune in to find out!About Our Guest:Ian Marks is a senior executive with over 25 years in the pharmaceutical and consumer healthcare industry. He has extensive experience delivering breakthrough innovations, leading disruptive initiatives, cultivating unorthodox partnerships, and building strategic capabilities that improve patients' lives and drive business value. His experience encompasses research and development, project management, clinical research and operations across Pharma and Consumer Healthcare. He has successfully leveraged ‘breakthrough’ results and superior performance to effectively merge patient insights, digital innovation, product development and compelling scientific discovery that identifies new products and experiences.

Visit the podcast's native language site